Plasmodium falciparum surf4.1 in clinical isolates: From genetic variation and variant diversity to in silico design immunopeptides for vaccine development
Saved in:
| Main Authors: | Nitchakarn Noranate, Jariya Sripanomphong, Fingani Annie Mphande- Nyasulu, Suwanna Chaorattanakawee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11684625/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmodium falciparum surf4.1 in clinical isolates: From genetic variation and variant diversity to in silico design immunopeptides for vaccine development.
by: Nitchakarn Noranate, et al.
Published: (2024-01-01) -
In vitro and in silico investigations of Propolis-derived phytochemicals as potential inhibitors of Plasmodium falciparum
by: Dhrubo Ahmed Khan, et al.
Published: (2025-06-01) -
Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal
by: Rokhaya Sané, et al.
Published: (2025-05-01) -
Functional immunopeptides: advancing prevention and therapeutic strategies against animal diseases
by: Aldryan Cristianto Pratama, et al.
Published: (2025-05-01) -
Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.
by: Kavita Gandhi, et al.
Published: (2014-01-01)